Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$63.14 Mil
% of Total Estimate Gain
166.62%

Frazier Life Sciences Management, L.P.'s Edgewise Therapeutics Inc Holding Summary

As of 2025-03-31, Frazier Life Sciences Management, L.P. held - shares of Edgewise Therapeutics Inc(EWTX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Frazier Life Sciences Management, L.P. now holds 0% of the outstanding Edgewise Therapeutics Inc(EWTX) stock.

The initial trade took place in 2023Q1. And since then Frazier Life Sciences Management, L.P. has made 6 purchases of EWTX, at an average price of $10.16, for a total of 3.73 Mil shares. In addition, there have been 3 sales at an average price of $27.08 for 3.73 Mil shares. Based on historical transaction data and EWTX's current price of $13.39, Frazier Life Sciences Management, L.P.'s estimated gain on his EWTX holdings is $63.14 Mil, reflecting a 166.62% gain to date.

Frazier Life Sciences Management, L.P. EWTX ($13.39) Holding Chart

Frazier Life Sciences Management, L.P. EWTX ($13.39) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1